MyFinsight
Home
Blog
About
Contact
Back
Income Statement
Celldex Therapeutics, Inc. (CLDX)
Celldex Therapeutics, Inc. (CLDX)
source: myfinsight.com
Download
Download image
Comprehensive loss
-$79,789K
(-49.02%↓ Y/Y)
Net loss
-$78,685K
(-46.27%↓ Y/Y)
Unrealized (gain) loss on
marketable securities
-$1,104K
(-534.65%↓ Y/Y)
Investment and other
income, net
$5,750K
(-35.70%↓ Y/Y)
Operating loss
-$84,435K
(-34.58%↓ Y/Y)
Total revenues
$15K
(-97.84%↓ Y/Y)
Total operating
expenses
$84,450K
(33.13%↑ Y/Y)
Research and development
$73,001K
(38.75%↑ Y/Y)
General and
administrative
$11,449K
(5.81%↑ Y/Y)
Back